Better Bet Than National Healthcare Stock: Pay Less To Get More From NUTX

NHC: National Healthcare logo
NHC
National Healthcare

NUTX is NHC’s peer in Health Care Facilities industry that has:

1) Lower valuation (P/OpInc) compared to NHC
2) But higher revenue and operating income growth

This disconnect between valuation and performance could mean that you are better off buying NUTX stock vs. NHC

Key Metrics Compared

Relevant Articles
  1. What’s Behind SoFi Stock’s 101% Surge?
  2. Why Has Newmont Stock Surged 135%?
  3. Why Did Okta Stock Drop 20%?
  4. Salesforce’s Pivot: Why “Agentforce” Matters More Than the Earnings Beat
  5. RBRK Stock Analysis: Strong Growth Meets Rich Valuation
  6. Why Zscaler’s 27% Crash Is the Ultimate Test for Software Investors

Metric NHC NUTX
P/OpInc* 14.6x 2.5x
LTM OpInc Growth 63.1% 4652.6%
3Y Avg OpInc Growth 47.5% 1546.2%
LTM Revenue Growth 23.8% 141.3%
3Y Avg Revenue Growth 11.1% 44.6%

OpInc = Operating Income, P/OpInc = Price To Operating Income Ratio

But do these numbers tell the full story? Read Buy or Sell NHC Stock to see if National Healthcare still has an edge that holds up under the hood. As a quick background, National Healthcare (NHC) provides management and services for skilled nursing, assisted living, homecare, hospice agencies, independent living facilities, and a behavioral health hospital.

This is just one approach to evaluate investments. Trefis High Quality Portfolio evaluates much more, and is designed to reduce stock-specific risk while giving upside exposure

Is The Mismatch In Stock Price Temporary

One way to check if National Healthcare stock is expensive now versus the other tickers would be to see how these metrics compared across companies exactly a year ago. Specifically, if there has been a marked reversal in the trend for National Healthcare in the last 12 months, then there is a chance that the current mismatch is likely to reverse. On the other hand, a persistent underperformance in revenue and operating income growth for National Healthcare would reinforce the conclusion that the stock is expensive compared to its peers, but may not revert soon

Key Metrics Compared 1 Yr Prior

Metric NHC NUTX
P/OpInc* 18.5x 0.8x
LTM OpInc Growth 66.6% 9226.9%
3Y Avg OpInc Growth 55.3% 3063.4%
LTM Revenue Growth 17.6% 93.8%
3Y Avg Revenue Growth 9.5% 31.9%

OpInc = Operating Income

Additional Metrics To Consider

Metric NHC NUTX
P/S 1.2x 0.8x
Market Cap (Current) $ 1.7 Bil $ 530.6 Mil
LTM Revenue $ 1.46 Bil $ 624.28 Mil
LTM Opinc $ 116.56 Mil $ 208.46 Mil
LTM Op Margin 8.0% 33.4%

OpInc = Operating Income

Alternate buying based on valuation, while attractive, needs to be evaluated carefully from multiple angles. Such multi-factor analysis is exactly how we construct Trefis portfolio strategies. If you want upside with a smoother ride than an individual stock, consider the High Quality portfolio, which has outperformed the S&P, and clocked >91% returns since inception.